Teva Pharmaceutical Prices $4.9 Billion Senior Notes Offering

MT newswire2026/09/10 10:36

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

06:36 AM EDT, 09/10/2026 (MT Newswires) -- Teva Pharmaceutical Industries (TEVA) has priced an offering of about $4.9 billion of senior notes across euro- and dollar-denominated tranches, the company said Thursday. The offering includes 1 billion euros ($1.16 billion) of 4.25% senior notes due 2033; 500 million euros of 4.625% notes due 2036; $1 billion of 5.5% notes due 2034; $1 billion of 5.75% notes due 2037, and $1.2 billion of 5.25% notes due 2032, the company said. Net proceeds, together with cash on hand, will be used to fund conditional redemptions, pay fees and expenses, as well as for general corporate purposes. Settlement is expected on or about Sept. 16, subject to customary closing conditions, Teva said.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

US Treasury Secretary Janet Yellen stated that there are "ways" to implement the plan without increasing the deficit, but did not disclose specific cost-offset measures. She noted that the Treasury has studied this for "quite some time," and emphasized that "putting more money in Americans' pockets should be everyone's goal." House Speaker Mike Johnson said he had communicated with the President on this issue the previous night, but specific details have not yet been finalized, and it will take some time before the plan is implemented.

华尔街见闻•2026/09/15 22:46

Claude AI Predicts Where Solana Could Land by the End of 2026

Coinspeaker•2026/09/15 22:27